Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels
← catalyst calendarSponsored by Gaia AG (industry) · GAIA — their whole pipeline →. With University of Kiel.
Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
278actual
Sites
1
Country
Germany
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-02-03 | actual | When the study began enrolling |
| Primary completion | 2026-05-22 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-05-22 | actual | The whole study's end, after follow-up |
| First posted | 2023-08-14 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-07 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Hypercholesterolemia
- Dyslipidemias
Intervention
- Behavioral: lipodia
Primary outcome
what the primary-completion date above is the date OFFasting LDL-C levels
measured 6 months
Permalink · GAIA's whole pipeline · Catalyst calendar · Every registered study · What changed